Welcome to the
Sugarbaker Oncology Associates Home Page

 http://surgicaloncology.com/WHC2CI.GIF

 

Paul H. Sugarbaker, MD, FACS, FRCS

 

 

http://surgicaloncology.com/banner.gif

We are the Center for Surgical Oncology at the Washington Cancer Institute, Washington Hospital Center, in Washington, D.C. We specialize in the surgical treatment of cancers that arise in the gastrointestinal tract (appendix cancer, colon cancer, and rectal cancer); and other areas of the abdomen and pelvis.

Our advanced services include specialty treatment programs for pseudomyxoma peritonei, peritoneal metastases (cancers that have spread to the intraabdominal surfaces), as well as primary peritoneal surface malignancies such as peritoneal mesothelioma.



http://surgicaloncology.com/btnmeso.jpg

http://surgicaloncology.com/btnpmp.jpg

http://surgicaloncology.com/btnpc.jpg

http://surgicaloncology.com/btncr.jpg

  

New and recent medical articles/journals authored or co-authored by Dr. Sugarbaker:

1.                Sugarbaker PH, Yoo D, Stuart OA, Bijelic L.  Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer.  (In) Rahman A, Zaman K (Editors). Topics in Anti-Cancer Research.  Bentham Science Publishers: Oak Park, IL, 2012, pp. 176-191.

 

2.                Sugarbaker PH. Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care. Surg Oncol Clin N Am. 2012 Oct;21(4):689-703. doi: 10.1016/j.soc.2012.07.009. PubMed PMID: 23021724.

 

3.                Van der Speeten K, Anthony Stuart O, Sugarbaker PH. Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy. Surg Oncol Clin N Am. 2012 Oct;21(4):577-97. doi: 10.1016/j.soc.2012.07.013. PubMed PMID: 23021717.

 

4.                Yonemura Y, Li Y, Sugarbaker PH, Piso P (Editors). Peritoneal metastases. Gastroenterol Res Pract. 2012;2012:695351. Epub 2012 Sep 12. PubMed PMID: 23008700; PubMed Central PMCID: PMC3449127.

 

5.                Preti V, Chang D, Sugarbaker PH. Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients. Gastroenterol Res Pract. 2012;2012:635314. Epub 2012 Aug 13. PubMed PMID: 22927838; PubMed Central PMCID: PMC3425016.

 

6.                Bijelic L, Kumar AS, Stuart OA, Sugarbaker PH. Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. Gastroenterol Res Pract. 2012;2012:163284. Epub 2012 Jul 26. PubMed PMID: 22899903; PubMed Central PMCID: PMC3412098.

 

7.                Sugarbaker PH, Bijelic L. Adjuvant bidirectional chemotherapy using an intraperitoneal port. Gastroenterol Res Pract. 2012;2012:752643. Epub 2012 Jul 24. PubMed PMID: 22888340; PubMed Central PMCID: PMC3409540.

 

8.                Sugarbaker PH. Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? Gastroenterol Res Pract. 2012;2012:309417. Epub 2012 Jul 19. PubMed PMID: 22888335; PubMed Central PMCID: PMC3408708.

 

9.                Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol. 2012 Aug;13(8):e362-9. doi:10.1016/S1470-2045(12)70210-3. PubMed PMID: 22846841.

10.           Bijelic L, Sugarbaker PH, Stuart OA. Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacological data in 34 patients. Gastroenterol Res Pract. 2012;2012:827534. Epub 2012 Jul 3. PubMed PMID: 22811702; PubMed Central PMCID: PMC3395133.

 

11.           Van der Speeten K, Govaerts K, Stuart OA, Sugarbaker PH. Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients. Gastroenterol Res Pract. 2012;2012:378064. Epub 2012 Jun 13. PubMed PMID: 22778722; PubMed Central PMCID: PMC3384921.

 

12.           Sugarbaker PH, Chang D, Stuart OA. Hyperthermic intraoperative thoracoabdominal chemotherapy. Gastroenterol Res Pract. 2012;2012:623417. Epub 2012 May 10. PubMed PMID: 22654899; PubMed Central PMCID: PMC3357938.

 

13.           Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012 Jul 10;30(20):2449-56. Epub 2012 May 21. PubMed PMID: 22614976.

 

14.           Bijelic L, Sugarbaker PH. The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer. Ann Ital Chir. 2012 May-Jun;83(3):224-31. PubMed PMID: 22595734.

 

15.           Sugarbaker PH, Stuart OA, Eger C. Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication. Gastroenterol Res Pract. 2012;2012:471205. Epub 2012 Apr 5. PubMed PMID: 22548052; PubMed Central PMCID: PMC3328159.

 

16.           Cao C, Yan TD, Morris DL, van der Speeten K, Laurberg S, Glehen O, Link K, Piso P, Tentes AA, Deraco M, Larsen SG, Kecmanovic D, Bayón LG, Melero JT, González-Moreno S, Mahteme H, Gertsch P, Moran B, Esquivel J, Alexander R, Levine EA, Sugarbaker PH. Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale. Tumori. 2012 Jan-Feb;98(1):166-71. doi: 10.1700/1053.11517. PubMed PMID: 22495719.

 

17.           Sugarbaker PH. Parietal peritonectomy. Ann Surg Oncol. 2012 Apr;19(4):1250. Epub 2012 Feb 10. PubMed PMID: 22322950.

 

18.           Cao C, Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH; Peritoneal Surface Malignancy Group. Importance of gender in diffuse malignant peritoneal mesothelioma. Ann Oncol. 2012 Jun;23(6):1494-8. Epub 2011 Nov 4. PubMed PMID: 22056853.

 

19.           Sugarbaker PH, Stuart OA, Bijelic L. Intraperitoneal gemcitabine chemotherapy as an adjuvant treatment for patients with resected pancreatic cancer: Phase II and pharmacologic studies. Transl Gastrointest Cancer 2012;1(2):161-168. DOI: 10.3978/j.issn.2224-4778.2012.06.04

 

20.           Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, 2012.

 

21.           Sugarbaker PH.  An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy. (In) Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, 2012, pp. 1-30.

 

22.           Sugarbaker PH.  Pseudomyxoma peritonei and peritoneal metastases from appendiceal malignancy. (In) Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, 2012, pp. 57-78.

 

23.           Glehen O, Yonemura Y, Sugarbaker PH.  Prevention and treatment of peritoneal metastases from gastric cancer. (In) Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, 2012, pp. 79-94.

 

24.           Sugarbaker PH.  Sarcomatosis and imitanib-resistant gistosis: Diagnosis and therapeutic options. (In) Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, 2012, pp. 127-136.

 

25.           Sugarbaker PH.  Management of unusual abdominal and pelvic neoplasms with peritoneal dissemination: Case reports and literature review. (In) Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, 2012, pp. 137-158.

 

26.           Van der Speeten K, Stuart OA, Sugarbaker PH.  Pharmacology of perioperative cancer chemotherapy. (In) Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, 2012, pp. 159-182.

 

27.           Sugarbaker PH, van der Speeten K, Stuart OA, Chang D, Mahteme H.  Patient- and treatment-related variables, adverse events and their statistical relationship for treatment of peritoneal metastases. (In) Sugarbaker PH (Editor). Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, 2012, pp. 183-206. 

 

Check out our web publications!

http://surgicaloncology.com/check.jpg

Management of Peritoneal Surface Malignancy Using
Intraperitoneal Chemotherapy and Cytoreductive Surgery:
A Manual for Physicians and Nurses

http://surgicaloncology.com/check.jpg

Atlas of Appendix Cancer and Pseudomyxoma Peritonei

http://surgicaloncology.com/check.jpg

Management of Peritoneal Surface Malignancy:
Appendix Cancer and Pseudomyxoma Peritonei, Colon Cancer, and Primary Peritoneal Malignancy

http://surgicaloncology.com/check.jpg

Hyperthermic Intraoperative Intraperitoneal Chemotherapy Tutorial

http://surgicaloncology.com/check.jpg

Protocol for the Implementation of Treatment of Patients with Peritoneal Surface Malignancy with Hyperthermic Intraoperative Intraperitoneal Chemotherapy and Normothermic Early Postoperative Intraperitoneal Chemotherapy

http://surgicaloncology.com/check.jpg

Technical Handbook for the Integration of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy into the Surgical Management of Gastrointestinal and Gynecologic Malignancy



http://surgicaloncology.com/world.jpg

We are pleased to introduce our list of international colleagues.




Introduction to SOAIntroduction to SOA

Introduction to SOAQuick Tour of Our Web Site

Introduction to SOAQuick Tour of Washington Hospital Center

Introduction to SOAResources for Patients and Families

Introduction to SOAResources for Medical Professionals

Introduction to SOAFARGO

Introduction to SOAYour Surgery & Hospitalization: What to Expect




Please contact us at:

Sugarbaker Oncology Associates
Washington Hospital Center

106 Irving St., NW, Suite 3900
Washington, D.C. 20010


Phone 202-877-3908
Fax 202-877-8602

http://surgicaloncology.com/mailbox.gif



You are visitor number
Hit Counter


Copyright 1996
Sugarbaker Oncology Associates
Washington Hospital Center
106 Irving St., NW, Suite 3900N
Washington, D.C. 20010

All Rights Reserved


Last Revised 12/28/2012